Cargando…
Induction Chemotherapy for Orbit Preservation in Sinonasal Squamous Cell Carcinoma
Sinonasal squamous cell carcinoma (SNSCC) is a rare and aggressive malignancy which often presents at an advanced stage. The gold-standard treatment includes negative-margin surgical resection plus adjuvant therapy. In cases of orbital invasion, surgery requires orbital exenteration which can carry...
Autores principales: | Lilly, Gabriela, Geltzeiler, Mathew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481003/ https://www.ncbi.nlm.nih.gov/pubmed/34603932 http://dx.doi.org/10.1055/s-0041-1736160 |
Ejemplares similares
-
Induction Chemotherapy for Locoregionally Advanced Sinonasal Squamous Cell Carcinoma and Sinonasal Undifferentiated Carcinoma: A Comprehensive Review
por: Melder, Katie L., et al.
Publicado: (2023) -
Sinonasal Undifferentiated Carcinoma with Failed Response to Induction Chemotherapy
por: Papazian, Michael R., et al.
Publicado: (2022) -
Sinonasal Squamous Cell Carcinoma Survival Outcomes Following
Induction Chemotherapy vs Standard of Care Therapy
por: Murr, Alexander T., et al.
Publicado: (2022) -
Sinonasal Lymphoepithelial Carcinoma With Aggressive Orbital Invasion
por: Suparmaniam, Sruban, et al.
Publicado: (2022) -
Orbital Apex Syndrome Secondary to SMARCB1-Deficient Invasive Sinonasal Carcinoma
por: Massey, Denzel, et al.
Publicado: (2022)